Traders should monitor for a potential near-term catalyst event or DTC filing that could explain the Q3 cluster — the conviction doubling by Citadel and Franklin suggests a material thesis catalyst in the 6-month window. Watch for Phase 3 data, licensing, or partnership announcements.
Executive Summary
A clear bullish institutional cluster emerged in LENZ during Q3 2025: 8 buyers (net +$108.9M) vs 3 sellers (net -$5.8M). Aggressive doubling by Citadel (+4320%), Franklin Resources (+6756%), and BofA (+414%) signals conviction around LENZ's presbyopia-correcting eye-drop franchise ahead of potential catalyst events. The buying is dominated by active managers and quant funds — not passive rebalancing — amplifying signal quality.
Key Financial Metrics
Institutional Positions
Net institutional flow: $108.9M
▲ Buyers (8)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| T. Rowe Price | DOUBLED | +1581.7% | $12.0K | $11.0K |
| Invesco | ADD | +36.6% | $17.0M | $9.2M |
| Citadel | DOUBLED | +4319.9% | $18.6M | $18.3M |
| BofA | DOUBLED | +413.6% | $16.3M | $14.3M |
| Wellington Management Group | ADD | +76.1% | $2.9M | $1.8M |
| UBS | ADD | +36.3% | $56.0M | $30.1M |
| Franklin Resources | DOUBLED | +6756.1% | $27.3M | $27.1M |
| Nuveen | ADD | +60.2% | $13.3M | $8.1M |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | TRIM | -49.4% | $17.2M | -$3.4M |
| Point72 | TRIM | -45% | $18.1M | -$2.3M |
| Ubs Am, A Distinct Business Un | TRIM | -53.5% | $737.0K | -$192.4K |
Key Facts
- 8 institutional buyers across Q3 2025 added a net $108.9M in LENZ positions; 3 sellers reduced holdings by $5.8M
- Citadel DOUBLED its position +4320% (to 399.4K shares worth $18.6M), Franklin Resources DOUBLED +6756% (to 587.1K shares worth $27.3M)
- UBS added +$30.1M to become the largest disclosed holder at $56.0M (1.20M shares)
- Only 3 sellers, all TRIMs (no full exits): Morgan Stanley -$3.4M, Point72 -$2.3M, UBS AM -$192K
- Aggregate buyer holdings rose to $151.3M, dwarfing the $30.1M seller side
- The 13F disclosure lag (45 days post-quarter) means these positions may already be partially unwound — but the cluster emerged before recent stock weakness
Financial Impact
8 buyers deployed net $108.9M into LENZ in Q3 2025, representing roughly 53% of the current $206M market cap being accumulated by tracked institutions
Risk Factors
- 13F data is 45+ days stale — cluster may have been partially or fully reversed before disclosure
- Market cap of $206M makes LENZ a small-cap biotech subject to binary trial outcomes and liquidity gaps
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-LENZ-2025-Q3 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | Press Release | $3.25 | awaiting T+1 | — | — |
Oct 21, 2026 5d ago | SC 13G/A | $3.25 $3.16 | ▼ −2.77% | ▼ −2.25% | — |
Aug 11, 2026 10w ago | Press Release | $5.04 $4.60 | ▼ −8.73% | ▼ −9.43% | — |
Jul 2, 2026 16w ago | 8-K | $5.89 $5.60 | ▼ −4.92% | ▼ −5.80% | — |
Jun 11, 2026 19w ago | Institutional Cluster | $6.50 $6.77 | ▲ +4.15% | ▲ +3.61% | — |
Jun 7, 2026 20w ago | Press Release | $6.72 $6.79 | ▲ +1.04% | ▲ +1.34% | — |
May 11, 2026 24w ago | 8-K | $7.91 $7.91 | · 0.00% | ▼ −0.54% | — |
May 4, 2026 25w ago | Press Release | $9.28 $9.07 | ▼ −2.26% | ▼ −3.06% | — |
Mar 24, 2026 30w ago | Press Release | $9.03 $9.07 | ▲ +0.44% | ▼ −0.12% | — |
Feb 28, 2026 34w ago | Institutional Cluster | $13.68 $13.15 | ▼ −3.87% | ▼ −2.96% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers